Company news
PAVmed Inc. news in 2021
PAVmed Inc.'s news releases, calls and decks from 2021, newest first.
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
November 30, 2021
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
November 15, 2021
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
October 24, 2021
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
October 6, 2021
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
August 11, 2021
PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
August 9, 2021
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
August 2, 2021
CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
August 1, 2021
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
July 21, 2021
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
June 9, 2021
PAVmed Launches Digital Health Company Veris Health Inc.
June 1, 2021
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
May 25, 2021
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 24, 2021
PAVmed Provides Business Update and First Quarter 2021 Financial Results
May 16, 2021
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
May 12, 2021
PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
May 5, 2021
PAVmed to Hold Business Update Conference Call on May 17, 2021
May 2, 2021
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
April 28, 2021
Global Industry Executive Debbie White Joins PAVmed Board of Directors
April 26, 2021
PAVmed Retires Convertible Debt
March 2, 2021
PAVmed Announces Closing of its Public Offering of Common Stock
February 24, 2021
PAVmed Announces Pricing of $45 Million Public Offering of Common Stock
February 22, 2021
PAVmed Announces Proposed Public Offering of Common Stock
February 21, 2021
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8: 30 AM EST
February 17, 2021
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
February 15, 2021
PAVmed to Hold Business Update Conference Call on February 22, 2021
February 8, 2021
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 7, 2021
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
January 5, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (April 2021)
Investor deck · 50 slides · Apr 19, 2021